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The present study was carried out to evaluate in vivo and in vitro anti-inﬂammatory potential of selected
medicinal plants used in Indian traditional medication. The sequentially extracted plant samples as,
Cissus quadrangularis, Plumbago zeylanica, Terminalia bellarica and Terminalia chebula in water, ethanol
and hexane were evaluated in-vitro for COX-1 and 2 inhibitory and antioxidant activities. The in vivo anti-
inﬂammatory activity of selected samples showing promising COX-2 inhibition was assessed using
carrageenan and Phorbol Myristate Acetate (PMA) induced mice edema animal model. The results ob-
tained reveals that most of the plants were found to inhibit COX-2 activity as compared to COX-1. It was
observed that the extracts of T. bellarica (73.34 %) and T. chebula (74.81 %) showed signiﬁcant COX-2
selective inhibition as compared to other samples. The ethanol extract of the selected plants demon-
strated effective DPPH, OH and superoxide radical scavenging activity. In vivo anti-inﬂammatory study
shows that, T. bellarica and T. chebulla had a signiﬁcant impact on inhibition of edema formation. The
cytotoxicity evaluation study of ethanolic fraction of selected medicinal plants indicates that the selected
samples have no effect on cell viability. HPTLC ﬁngerprint of ﬂavonoids of the selected samples was also
prepared as a measure of quality control. The results obtained may be useful in strengthening the
standardization of the selected botanicals. Moreover the selected plants can be considered as a resource
for searching novel anti-inﬂammatory agents possessing COX-2 inhibition.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cyclooxygenase also abbreviated as COX, is a prostaglandin
endoperoxide synthase (E.C. 1.14.99.1) enzyme involved in the
metabolism of arachidonic acid (AA) and synthesis of prostanoid
including potent proinﬂammatory prostaglandins (PGE2, PGF2a).1,2
In mammalian cells, COX exist in at least two isoforms COX-1 and
COX-2.3e5 COX-1 is expressed constitutively in almost all cell types,
including platelets and those present in stomach, kidney, vascular
endothelium, forebrain and uterine epithelium and is regulated as a
house keeping enzyme for various physiological functions, whereas
COX-2 is inducible and expressed during tissue damage orona College, Camp, Pune 411
0) 20 26453707.
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).inﬂammation in response to proinﬂammatory cytokines such as IL-
1b, interferon gamma and TNF-a.6e8 A crucial proinﬂammatory role
played by the COX hasmade this enzyme an attractive target for the
design and development of novel anti-inﬂammatory agents.
Although, role of free radical in inﬂammatory reactions is well
described. The free radicals especially, the reactive oxygen species
(ROS) creates oxidative stress in the cells leading to inﬂammatoryand
infectious condition. Phagocytic cells including polymorphonuclear
leukocytes (neutrophils, eosinophils) and mononuclear cells
(macrophage and lymphocytes) produce excessive amount of ROS
which play an important role in the host defensemechanism. Besides
their defensive effects these excessively producedROSderegulate the
cellular functions causing cellular and tissue damage, which in turn
augments the state of inﬂammation.9e11
Non steroidal anti-inﬂammatory drugs (NSAIDs) represent one of
the most common classes of medications used world wide with an
estimated usage of >30million per day for inﬂammation and related
disorders.12 Most of the NSAIDs are carboxylic acid containing drugsrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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acid derivatives (indomethacin), propionic acid derivatives
(ibuprofen, ketoprofen, ﬂurbiprofen) and phenyl acetic acid de-
rivatives (diclofenac). These organic acid containing drugs act at the
active site of the enzyme preventing the access of arachidonic acid
(AA) to the enzyme and stop the cyclooxygenase pathway.13,14 Un-
fortunately, besides the excellent anti-inﬂammatory potential of the
NSAIDs, the severe side effects such as gastrointestinal (GI) ulcera-
tion, perforation, obstruction, and bleeding has limited the thera-
peutic usage of NSAIDs.15,16 The mucosal irritation occurs due to the
acidic nature of most of NSAIDs and inhibition of production of
mucosal protective PGE which leads to gastric erosion.17 This is
consistent with the idea that inhibition of COX-1 underlies the
gastrointestinal side effects of NSAIDs and that NSAIDs selectivity
toward inhibition of COX-1 over COX-2 correlateswith their ability to
cause gastrointestinal side effects.18e20 A recent analysis found that
there is increased cardiovascular risk,21 hypertension and
edema,22e25 and cause nephrotoxicity,26 in patients who are at risk
with COX-2 inhibitors. Searching selective COX-2 inhibitors without
inﬂuencing the normal physiological functions of COX-1 has
remained a major thrust area of anti-inﬂammatory pharmaceutical
research. Nevertheless, the anti-inﬂammatory agents having selec-
tive COX-2 inhibition but less reactive towards COX-1 are appreci-
ated as novel anti-inﬂammatory agents in the mainstream of anti-
inﬂammatory research.27
According to World Health Organization (WHO), about three-
quarters of the world population depends on traditional medi-
cines (mainly herbs) for their healthcare. Ayurveda and Chinese
medicinal systems are the most acceptable traditional system
which has a considerable amount of research on pharmacognocy,
chemistry, pharmacology and clinical therapeutics.28,29 It is evident
that several plants have been used in traditional ayurvedic medi-
cine for treatment and management of distinct inﬂammatory dis-
orders and wound healing activities.30 There is clear evidence
addressing the importance of plant derived COX inhibitors in the
management of inﬂammatory disorders. Baumann and coworkers
were the ﬁrst to report in a study that some dietary polyphenols
inhibit arachidonic acid peroxidation.31 Since then several re-
searches have reported that many dietary polyphenols possess
COX-2 inhibitory or stimulatory effects.32e34 In the recent years, the
use of traditional medicine information on plant has again received
considerable interest. The renewed interest in medicinal plant
research has focused on herbal cures among indigenous pop-
ulations around the world. Nevertheless, the standardization of
botanicals has remained a key issue to be addressed to the con-
sumers and for the popularization of herbal drugs all over the
world. Hence, ethanopharmacology and drug discovery using nat-
ural products has remained an important issue in the current
target-rich, lead-poor scenario of pharmaceutical research.35
Taking into consideration the above facts, an attempt has been
made to standardize the selected botanicals as anti-inﬂammatory
agents using COX guided activity. The antioxidant potential and
cytotoxicity proﬁle have also been carried out to supplement the
results.
2. Materials and methods
2.1. Materials
The COX-1 & 2 (human ovine) inhibitor Screening assay kit
[Catalog No. 760111] was procured from Cayman, U.S.A., MTT (3- (4,
5-dimethylthiazol-2-yl) e 2, 5- diphenyl tetrazolium bromide),
DPPH (1, 1-diphenyl-2-picryl hydrazyl) were purchased from
Sigma-Aldrich Co. (St. Louis MO, USA). 1e10 phenanthroline,
Phenazinemethosulphate (PMS), Nitroblue tetrazolium (NBT) wereobtained from s.d. Fine chem. Mumbai. Nicotinamide Adenine
Dinucleotide (NADH) was purchased from Spectrochem, Pvt. Ltd.
Mumbai. Chang Liver cell line was requested from National Centre
for Cell Science (NCCS: a National Cell Line Facility) Pune (MS),
India. Medicinal plants were collected from the nearby areas of
Nanded district (MS), India. All other chemicals and reagents used
were of AR grade and were obtained from commercial sources.2.2. Collection and identiﬁcation of the selected medicinal plants
The selected plants Cissus quadrangularis (A-13), Plumbago zey-
lanica (A-15), Terminalia bellarica (A-16) and Terminalia chebulla
(A-17) were collected from the nearby regions of Nanded district
(MS). The plants were identiﬁed and authenticated with the help of
Flora36 and Voucher specimens (A13-A17) of the plants were
deposited in the herbarium center of Department of Botany, School
of Life Sciences, Swami Ramanand Teerth Marathwada University,
Nandede 431606 (MS), India. The shade dried and powdered plant
samples were preserved for further experimentations.2.3. Sequential extraction of the plant samples
The shed dried powdered plant samples (10 g) were sequen-
tially extracted in hexane, ethanol and water up to 8 h using
Soxhlet's apparatus. The extracted samples were evaporated under
reduced pressure at room temperature. The dried extracts were
preserved at 4 C in refrigerator for further analysis.2.4. HPTLC analysis
HPTLC analysis was performed using CAMAG (Germany) make
instrumental thin layer chromatography. TLC plates (Merck silica gel
60 F254, 20 cm  10 cm) were prewashed with methanol. The plate
was activated in an oven at 100 C for 10 min. Individual plant ex-
tracts of 10 ml (1 mg/ml) were spotted onto the precoated plates
using a Linomat 5 application system. Rutin hydrate (5 and 10 mg/ml)
was used as amarker ﬂavonoid. The ﬂavonoids were separated using
ethyl acetate: formic acid: glacial acetic acid: water (100:11:11:27) as
amobile phase. Natural product (NP) reagentwas used as a ﬂavonoid
derivatizing agent and the spots developed were visualized under
CAMAGUV cabinet (366 nm) andwere digitized using CAMAGphoto
documentation system.2.5. COX inhibition assay
The assay was performed by using Colorimetric COX (human
ovine) inhibitor Screening assay kit.37 Brieﬂy, the reaction mixture
contains, 150 ml of assay buffer, 10 ml of heme, 10 ml of enzyme
(either COX-1 or COX-2), and 10 ml of plant sample (1 mg/ml). The
assay utilizes the peroxidase component of the COX catalytic
domain. The peroxidase activity was assayed colorimetrically by
monitoring the appearance of oxidized N, N, N, N'-tetramethyl-p-
phenylenediamine (TMPD) at 590 nm. Aspirin (acetylsalicylic acid,
1 mM)was used as a standard drug. The percent COX inhibitionwas
calculated using following equation:
COX inhibition activity ð%Þ ¼ 1 T
C
 100
Where T ¼ Absorbance of the inhibitor well at 590 nm.
C ¼ Absorbance of the 100 % initial activity without inhibitor
well at 590 nm.
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DPPH radical scavenging assay was carried out as per reported
method with slight modiﬁcations.38,39 Brieﬂy, 1 ml of test sample
(1 mg/ml) was added to equal quantity of 0.1 mM solution of DPPH
in ethanol. After 20 min of incubation at room temperature, the
DPPH reduction was measured by reading the absorbance at
517 nm. Ascorbic acid (1 mM) was used as reference compound.
2.7. Hydroxyl (OH) radical scavenging assay
The OH radicals scavenging activity was demonstrated with
Fenton reaction.40 The reaction mixture contained, 60 ml of FeCl2
(1 mM), 90 ml of 1e10 phenanthroline (1 mM), 2.4 ml of phosphate
buffer (0.2 M, pH 7.8), 150 ml of H2O2 (0.17 M) and 1.5 ml of indi-
vidual plant extract (1 mg/ml). The reaction was started by adding
H2O2. After 5 min incubation at room temperature, the absorbance
was recorded at 560 nm. Ascorbic acid (1 mM) was used as refer-
ence compound.
2.8. Superoxide radical (SOR) scavenging assay
The SOR scavenging assay was performed by the reported
method.41 Superoxide anion radicals were generated in a non-
enzymatic Phenazine methosulphate e Nicotinamide Adenine
Dinucleotide (PMS e NADH) system through the reaction of PMS,
NADH and Oxygen. It was assayed by the reduction of Nitroblue
tetrazolium (NBT). In this experiment superoxide anion was
generated in 3 ml of Tris HCL buffer (100 mM, pH 7.4) containing
0.75 ml of NBT (300 mM), 0.75 ml of NADH (936 mM), and 0.3 ml of
plant sample (1 mg/ml). The reaction was initiated by adding
0.75ml of PMS (120 mM) to themixture. After 5min of incubation at
room temperature the absorbance at 560 nm was measured in
spectrophotometer. Ascorbic acid (1 mM) was used as reference
compound.
2.9. MTT cytotoxicity assay
The MTT cytotoxicity assay was performed as published pre-
viously.42e44 The Chang liver cells were harvested (1.5  104 cells/
well) and inoculated in 96 well microtiter plates. The cells were
washed with phosphate buffered saline (PBS) and the cultured cells
were then inoculated with and without the individual ethanolic
plant extract (1 mg/ml). After 72 h incubation, the medium was
aspirated followed by addition of 10 mL of MTT solution (5 mg/ml in
PBS, pH 7.2) to each well and the plates were reincubated for 4 h at
37 C. After incubation time,100 mL of DMSOwas added to thewells
followed by gentle shaking to solubilize the formazan crystal for
15 min. Absorbance was read at 540 nm using Thermo make
Automatic Ex-Microplate Reader (M51118170) and the % cell
viability was calculated. The H2O2 (1 mM) was used as reference
cytotoxic agent. The percent DPPH, OH, SOR scavenging activity and
cell viability inhibition was calculated using following formula.
Inhibition activity ð%Þ ¼ 1 T
C
 100;
Where T ¼ Absorbance of the test sample.
C ¼ Absorbance of the control sample.
2.10. Experimental animals
The animals used in this study were Swiss albino mice weighing
between 25e30 g. They were maintained in experimental animal
house at Sudhakarrao Naik Pharmacy College, Pusad (MS), India.They were kept in rat cages and fed on standard mice food (Amrut
Feeds Ltd., Sangali (MS), India) and allowed free access to clean
fresh water in bottles. The experimental protocols were in
compliance with Institutional Animal Ethics Committee (IAEC),
Sudhakarrao Naik Pharmacy College, Pusad (MS), (Proposal No.
CPCSEA/IAEC/PL/09e2011).
2.11. Carrageenan-induced rat paw edema assay
The selected samples showing promising average (activity in all
solvents) COX-2 selective activities were evaluated for in vivo anti-
inﬂammatory studies using carrageenan induced rat paw edema
animal model. The assay performed as described previously.45
Brieﬂy, edema was induced on the right hind paw by subplantar
injection of 20 ml carrageenan (1 % w/v) in 0.9 % saline. The extract
of selected samples were prepared in 1 % w/v gum acacia and
administered orally at a dose of 100 mg/kg and 250 mg/kg, 1 h
before carrageenan injection. A control group received vehicle only
and a standard group was treated with indomethacin (20 mg/kg,
p.o.) The volume of injected and of the contra lateral paws was
measured 1, 3, and 5 h after induction of inﬂammation, using a
plethysmometer (Orchid Scientiﬁc Laboratory). The value was
expressed as, the percent reduction in volume with respect to the
control group of at different time intervals.
2.12. PMA induced mouse ear edema activity
According to a modiﬁed method of46 4 mg per ear of PMA, in
20 ml of acetone, was applied to both surfaces of the right ear of
each mouse. The left ear (control) received the vehicle (acetone
and/or DMSO, 20 ml). The selected plant extract was administered
topically (50 and 100 mg per ear in DMSO) 1 h before PMA appli-
cation. Two control groups were used: a control group with the
application of PMA on the right ear and the reference group was
treated with indomethacin (2 mg per ear in 20 ml acetone). Six
hours after PMA application, mice were killed by cervical disloca-
tion and a 6 mm diameter disc from each ear was removed with a
metal punch andweighed. Ear edemawas calculated by subtracting
the weight of the left ear (vehicle) from the right ear (treatment),
and was expressed as edema weight. Inhibition percentage was




The HPTLC analysis was performed as a part of quality control of
the selected plant samples. HPTLC ﬁnger print of ethanol soluble
ﬂavonoids was prepared using rutin as a marker ﬂavonoid com-
pound (Fig.1.). The results of the HPTLC analysis shows the diversity
of ﬂavonoid content in T. chebulla, moreover this is the only sample
containing rutin, while all other samples were devoid of rutin
content.
3.2. Effect of plant samples on COX inhibition
The results of the COX inhibition using different fractions of the
selected plants are summarized in (Tables 1 and 2). The average
COX-1 & 2 inhibition was calculated by taking the mean of COX
inhibition activity in three solvent extracts. Overall it was found
that the fractions of T. bellarica (mean activity COX-1, 61.83 % &
COX-2, 73.34 %) and T. chebulla (mean activity COX-1, 52.82 % &
COX-2, 74.38 %) were observed to be signiﬁcant inhibitors of COX-1
and 2, with more selectivity towards COX-2 inhibition as compared
Fig. 1. HPTLC proﬁle of ﬂavonoid ﬁnger prints of ethanol extract of selected medicinal
plants using Rutin as a marker compound. Track no. 1 e Plumbago zeylanica, 2 e Rutin
(5 mg), 3 e Rutin (10 mg), 4 e Terminalia bellarica, 5 e Terminalia Chebulla, 6 e Cissus
quadrangularis.
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C. quadrangularis demonstrated considerable COX-1 selective
(mean activity 53.25 %) inhibitory potential as compared to other
samples. The minimum COX-1 inhibition was shown by the water
extract of C. quadrangularis (28.18 %), whereas lower COX-2 inhi-
bition was shown by the P. zeylanica (mean activity 42.86 %). A
cursory look at the COX inhibition proﬁle by the selected plants also
shows that the ethanol fractions were found to be more effective
COX inhibitory agents as compared to water and hexane extracts,
which showed moderate or no inhibition. The results were
compared with Aspirin (1 mM) showing COX-1 (08.54 ± 0.37 %) and
COX-2 (11.11 ± .13 %)3.3. DPPH radical scavenging activity
The results are summarized in Table 3. It was observed that the
water and ethanol soluble contents of selected plants (1 mg/ml)
were found to be potent DPPH reducing agents. The maximum
DPPH radical scavenging activity was observed in ethanolic extractTable 1
Effect of different fractions of selected medicinal plants on COX-1 activity.
Sr. No. Name of plant samples Inhibition of COX-1 (%
Water
1 Cissus quadrangularis 28.18 ± 0.70
2 Plumbago zeylanica NR
3 Terminalia bellarica 75.16 ± 0.41
4 Terminalia chebulla 72.16 ± 0.93
5 Aspirin ND 08.54 ± 0.37 ND
Results summarized are the mean values of n ¼ 3 ± S.D., NR e no reaction under experi
Table 2
Effect of different fractions of selected medicinal plants on COX-2 activity.
Sr.No. Name of plant samples Inhibition of COX-2 (%
Water
1 Cissus quadrangularis 24.05 ± 0.64
2 Plumbago zeylanica 33.27 ± 0.74
3 Terminalia bellarica 88.79 ± 0.71
4 Terminalia chebulla 88.16 ± 0.73
5 Aspirin ND 11.11 ± .13 ND
Results summarized are the mean values of n ¼ 3 ± S.D., ND e not determined.of T. bellarica (85.89 ± 1.82 %) while the minimum activity was
observed in ethanolic extract of C. quadrangularis (8.99 ± 1.65 %). All
other samples showed DPPH reducing activity in the range of
5.37e84.19 % as compared with ascorbic acid (81.27 ± 0.87 %).
3.4. OH radical scavenging activity
The proﬁle of OH radical scavenging activity of selected me-
dicinal plants is shown in Table 3. Except water extract of T. bellarica
and T. chebulla, all samples are found to be promising OH radical
scavengers. The ethanol extract of P. zeylanica (96.59 ± 0.58 %)
possess maximum activity while ethanol extract of T. chebulla
(38.05 ± 0.77 %) showed poor OH radical scavenging ability as
compared to ascorbic acid (2.63 ± 0.73 %).
3.5. SOR scavenging assay
The results obtained are shown in Table 3. The water and
ethanolic extract of all selected plants showed promising SOR
scavenging activity as compared to hexane extract. The high SOR
scavenging activity was found in ethanolic extract of P. zeylanica
(57.21 %) while the lower SOR was reported in hexane extract of
C. quadrangularis (0.79 %.). From the tested samples it was observed
that the SOR scavenging activity was recorded in the range of
3.81e34.55 %. The results were compared with ascorbic acid
(52.95 ± 0.83 %).
3.6. MTT cytotoxicity assay
It was observed that none of the plant sample showed signiﬁ-
cant cytotoxic effect on normal Chang liver cell viability at 1 mg/ml
concentration. The observed and calculated percent inhibition of
cell viability of C. quadrangularis is (3.08 ± 0.41), P. zeylanica
(0.32 ± 0.17), T. bellarica (3.20 ± 0.63), and T. chebulla
(1.81 ± 0.57). The H2O2 (1 mM) was used as a standard cytotoxic
(3.13 ± 0.50 %) agent for comparison purpose.
3.7. Proﬁle of carrageenan induced anti-inﬂammatory activity
The results of the oral administration of P. zeylanica, T. bellarica
and T. chebulla plant extracts showed promising anti-inﬂammatory)
Ethanol Hexane Mean activity
84.94 ± 0.99 46.64 ± 0.69 53.25
41.48 ± 0.62 36.25 ± 0.54 25.91
62.24 ± 0.79 48.09 ± 0.56 61.83
86.32 ± 1.18 NR 52.82
ND
mental condition, ND e not determined.
)
Ethanol Hexane Mean activity
81.01 ± 0.62 47.92 ± 0.44 50.99
63.98 ± 0.51 31.35 ± 0.71 42.86
71.14 ± 0.90 60.09 ± 0.45 73.34
85.40 ± 0.97 50.88 ± 0.34 74.81
ND
Table 3
Antioxidant activity of selected medicinal plants.
Sr. No. Name of the plants Plant extracts % Radical scavenging activity
DPPH OH SOR
1 Cissus quadrangularis (W) 16.15 ± 1.32 86.47 ± 0.77 31.39 ± 1.18
(E) 8.99 ± 1.65 57.60 ± 0.85 03.81 ± 0.80
(H) 5.37 ± 1.06 52.73 ± 0.79 00.79 ± 0.51
2 Plumbago zeylanica (W) 52.61 ± 1.20 78.28 ± 0.56 14.60 ± 0.76
(E) 75.44 ± 0.77 96.59 ± 0.58 57.21 ± 0.88
(H) NR 62.89 ± 0.94 NR
3 Terminalia bellarica (W) 82.22 ± 1.39 NR 34.55 ± 0.91
(E) 85.89 ± 1.82 67.32 ± 1.22 22.21 ± 1.22
(H) NR 88.39 ± 0.95 NR
4 Terminalia chebula (W) 84.02 ± 1.22 NR 27.48 ± 0.92
(E) 84.19 ± 3.36 38.05 ± 1.22 25.55 ± 0.78
(H) NR 91.65 ± 1.11 NR
5 AA (E) 81.27 ± 0.87 2.63 ± 0.73 52.95 ± 0.83
Results presented here are the mean value of n ¼ 3; ± S.D., NR ¼ No reaction under experimental condition, (W) ¼Water, (E) ¼ Ethanol, (H) ¼ Hexane, AA ¼ Ascorbic acid.
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volume (Table 4). In the present studies carrageenan induced 69,
86, and 99 % edema formation at 1, 3 and 5 h respectively, compared
with 0 h readings in control group. It was observed that at a higher
dose of 250 mg/kg, T. bellarica (32.85 %) and T. chebulla (34.28 %)
showed signiﬁcant decrease in edema volume after 1 h. Moreover,
at the same dose of T. bellarica (22.77 %) and T. chebulla (20.80 %)
considerable reduction in the edema volume was observed, how-
ever only 10.34 and 17.34 % reduction in edema volume was
observed in respective samples after 3 h. Similar trend of results of
edema volume reduction was observed with a dose of 100 mg/kg.
The results were compared with standard anti-inﬂammatory drug
such as Indomethacin (20 mg/kg) which showed effective inhibi-
tion (51.48 %) at 5 h. One Way ANOVA for multiple comparison test
followed by dunnet test were performed to assign the level of
signiﬁcance.
3.8. Oedama induced by PMA in mouse ear activity
It can be seen in Table 5 that the selected plant samples inhibit
PMS indued inﬂammation in mouse ear. The extracts of T. chebulla
(54.06 %) and T. bellerica (47.84 %) shows signiﬁcant (P < 0.05)
inhibitory results as compare to P. zeylanica (30.21 %) at the higer
dose (100 mg/ear). Indomethacin was used as reference compound
also possess an excellent inhibitory activity.
4. Discussion
Developing novel, effective and safe anti-inﬂammatory agents
has remained a major thrust area in the main stream of ‘ﬁnding
alternatives to NSAID's. Anti-inﬂammatory agents possessing se-
lective COX-2 inhibition and showing no or negligible effect onTable 4
Summary of carrageenan induced anti-inﬂammatory activity of selected plants.
Sr. No. Name of the samples Dosage (mg/kg)
1 Control e
2 Indomethacin 20
3 Plumbago zeylanica 100
250
3 Terminalia bellarica 100
250
4 Terminalia chebulla 100
250
* (P < 0.05), ** (P < 0.01) indicates signiﬁcant decrease in the paw edema volume com
comparison test followed by dunnet test).COX-1 activity are more appreciated as safe drugs as these agents
have minimum gastrointestinal side effects. Natural product,
especially medicinal plants and drug discovery has remained a very
successful combination for the inventorization of new therapeutic
agents. The main intention of the present study was to perform the
COX activity guided standardization of selected medicinal plants
with focus on antioxidant and cytotoxicity proﬁle. Variety of phy-
tochemicals like ﬂavonoids, terpenoids, alkaloids and saponins has
been described to possess signiﬁcant anti-inﬂammatory activity.
Several studies proved that naturally occurring coumarins47 and
ﬂavonoids48 act as dual inhibitors of cyclooxygenase and 5-
lipoxygenase activities. The Indian spice turmeric, (Curcuma longa
L.) possessing curcumin (and synthetic analogs) have established
reputation as an anti-inﬂammatory agent by inhibiting COX-1 and
COX-2.49 Flavonoids inhibit biosynthesis of prostaglandins (the end
products of the COX and lipoxygenase pathways), which acts as a
secondary messengers and are involved in various immunologic
responses.50 Inhibition of these enzymes provides the mechanism
by which ﬂavonoids inhibit inﬂammatory disorders.51
Few years back, highly effective class of novel anti-inﬂammatory
drugs such as Celecoxib, Rofecoxib, and Valdecoxib etc. were
introduced in the pharmaceutical market but unfortunatelymost of
themwere withdrawn from the market on account of their serious
cardio functioning side effects, especially in high sensitive patients
like pregnant women, new born children, elderly people etc.15,16
Worldwide, there is an increasing concern in ﬁnding new anti-
inﬂammatory remedies not only having improved therapeutic in-
dex but also harmless. The results of the COX inhibition studies
focus the importance of selected botanicals as an important
resource for the isolation and identiﬁcation of new COX-2 selective
anti-inﬂammatory agents. The medicinal plants such as T. bellarica
and T. chebulla are one of the major constituents of a popularPercent inhibition of edema volume at different time intervals (hrs.)
1 3 5
69.24 ± 0.010 86.07 ± 0.010 99.93 ± 0.011
22.85 ± 0.108 26.43 ± 0.128* 51.48 ± 0.098**
21.54 ± 0.142 17.98 ± 1.012 15.59 ± 1.521
23.48 ± 1.860 18.56 ± 0.793 13.98 ± 0.154
27.14 ± 0.016 10.34 ± 0.012 13.86 ± 0.018
32.85 ± 0.013* 10.34 ± 0.020 22.77 ± 0.010*
25.71 ± 0.010 08.05 ± 0.014 07.92 ± 0.010
34.28 ± 0.016** 17.24 ± 0.010 20.80 ± 0.010*
pared to control value for respective time interval (One Way ANOVA for multiple
Table 5
Effect of plant samples on edema induced by PMS in mouse ear.
Sr. No. Name of the sample Dosage
(mg/ear)
PMA- induced ear edema
edema weight (mg) % Inhibition
1 PMA 0.004 16.45 ± 2.41 e
2 Indomethacin 2 04.88 ± 1.98 70.33
3 Plumbago zeylanica 50 12.85 ± 1.62 21.88
100 11.48 ± 1.54* 30.21
4 Terminalia bellarica 50 10.78 ± 0.15* 34.46
100 08.58 ± 2.35** 47.84
5 Terminalia chebula 50 10.89 ± 0.78* 33.79
100 07.56 ± 1.89** 54.04
* (P < 0.05), ** (P < 0.01) statistical signiﬁcance compared with PMA groups (One
Way ANOVA for multiple comparison test followed by dunnet test).
R.U. Shaikh et al. / Journal of Traditional and Complementary Medicine 6 (2016) 355e361360ayurvedic formulation ‘Triphala’, prescribed by most of the tradi-
tional healthcare practitioners as well as by clinical physicians in
India and many Asian countries.52 According to the traditional In-
dian medicinal system, especially in ayurveda, ‘Triphala’
strengthens and activates different tissues of the body, prevents
ageing and promotes health. It is also reputed for immunomodu-
latory properties which improves body's defense system.53 In
recent years there are several reports in the literature which sug-
gest that ‘Triphala’ possesses antimutagentic, radioprotecting and
antioxidant activity.54e56
A detailed review of literature reveals that the selected plants
have not been tested yet for their ability to manage inﬂammation
by selective inhibition of COX enzyme cascade, although they are
widely used in the management of diverse inﬂammatory disorders.
The study undertaken evidently demonstrates ﬁrst time, their
thriving activity for COX inhibition along with their in vivo anti-
inﬂammatory, antioxidant and cytotoxic activities.
Plethora of literature has accumulated in the past 15 years
linking the role of free radical species (superoxide, hydroxyl radi-
cals, nitric oxide, peroxynitrite, and the free radical-derived prod-
uct hydrogen peroxide) in initiating and modulating inﬂammatory
disorders. In support of this contention, several reports have shown
that administration of scavengers of free radicals or free radical
products to intact animals blunts or prevents reductions in muscle-
speciﬁc force generation in animal models of systemic inﬂamma-
tion.57,58 There is a strong need for effective antioxidants from
natural sources as alternatives to synthetic antioxidant in order to
prevent the free radicals implicated diseases which can have
serious effects on the cardiovascular system, either through lipid
peroxidation or vasoconstriction.59 The extracts and essential oils
of many plants have been investigated for their antioxidant
activity.60e62 The polyphenolic compounds are secondary plant
metabolites found in numerous plant species, these polyphenolic
compounds have been reported to play key antioxidant roles. The
phytochemicals especially the ﬂavonoids have been extensively
studied for their antioxidant activities using the mechanism of
delocalization of the single electron of the radical. The plants
studied in the present investigation demonstrated considerable
free radical scavenging activity, which could be supplementary for
the amelioration of inﬂammatory reactions.
Authenticity of the plant drugs and safety are the key issues in
the standardization of the botanicals. Nevertheless these issues
need to be addressed to the end users for their satisfaction and for
the popularization of the drugs from plant origin. The non toxic
nature of the selected plants addresses the safety issue of these
botanicals on health grounds.
In conclusion the results of the present study may strengthen
the process of standardization of botanicals containing the selected
plants as one of the ingredients. In many instances, the actual
compound/s isolated from the plants may not serve as the drug, butleads to the development of potential novel therapeutic agents.
With the rapid identiﬁcation of new molecules from plant re-
sources having signiﬁcant anti-inﬂammatory effects are proving to
be important agents in the mainstream of anti-inﬂammatory drug
discovery marathon.
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